Open
1.81 -1.31
24h
Min
1.804
Max
1.832
Income | -25M |
---|---|
Sales | 4.3M |
Profit margin | -570.732 |
Employees | 181 |
EBITDA | -23M |
Recommendations | Neutral |
---|---|
12 Months Forecast | +69.6% upside |
Next Earnings | 17 wrz 2025 |
---|
Market Cap | 172M |
---|---|
Previous open | 3.12 |
Previous close | 1.81 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 3.104 EUR 69.6%
High 3.1 EUR
Low 3.1 EUR
Based on 1 Wall Street analysts offering 12 month price targets forInnate Pharma SA - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$